Marketing and distribution deal reached between HRA Pharma and Nycomed
This article was originally published in Scrip
Executive Summary
HRA Pharma has signed a marketing and distribution agreement with Nycomed. The agreement will see Nycomed distribute and market HRA's next-generation emergency contraceptive ellaOne (ulipristal acetate) in the Nordic and Baltic territories, HRA says.